Suppr超能文献

同型半胱氨酸是脑小血管疾病的一个风险因素,通过内皮功能障碍起作用。

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.

作者信息

Hassan Ahamad, Hunt Beverley J, O'Sullivan Michael, Bell Rachel, D'Souza Reuben, Jeffery Steve, Bamford John M, Markus Hugh S

机构信息

Department of Clinical Neurosciences, St George's Hospital Medical School, London SW17 ORE, UK.

出版信息

Brain. 2004 Jan;127(Pt 1):212-9. doi: 10.1093/brain/awh023. Epub 2003 Nov 7.

Abstract

Cerebral small vessel disease (SVD) causes focal lacunar infarction and more diffuse ischaemia, referred to as leukoaraiosis. Endothelial dysfunction has been proposed as a causal mechanism in the disease. Homocysteine is toxic to endothelium. We determined whether elevated homocysteine levels and the methylene tetrahydrofolate reductase (MTHFR) C677T polymorphism are risk factors for SVD as a whole, and for two different SVD subtypes: isolated lacunar infarction and ischaemic leukoaraiosis. We also determined whether any association was mediated by endothelial dysfunction, as assessed by circulating endothelial markers. One hundred and seventy-two Caucasian patients with SVD and 172 community controls of similar age and sex were studied. Serum homocysteine measurement and MTHFR genotyping was performed. Levels of intercellular adhesion molecule 1 (ICAM1) and thrombomodulin were measured in a subgroup. Mean homocysteine levels were higher in SVD than controls [14.55 micromol/l [95% confidence interval (CI) 13.78-15.35] versus 12.01 micromol/l (95% CI 11.42-12.64), P < 0.0005]. Homocysteine was a stronger risk factor in those with ischaemic leukoaraiosis [12.92 (95% CI 4.40-37.98), P < 0.0005) per micromol increase in log homocysteine concentration (P < 0.0005)] in comparison with isolated lacunar infarction [4.22 (95% CI 1.29-13.73), P = 0.02] after controlling for both conventional risk factors and age. The MTHFR 677T allele was a risk factor only in the ischaemic leukoaraiosis group [odds ratio (OR) 2.02 (95% CI 1.31-3.1), P = 0.001]. Inclusion of the endothelial markers ICAM1 and thrombomodulin in a logistic regression model resulted in the association between homocysteine and SVD no longer being significant. In conclusion, hyperhomocysteinaemia is an independent risk factor for SVD, particularly ischaemic leukoaraiosis, and this effect may be mediated via endothelial dysfunction. Homocysteine-lowering therapy may be particularly effective in this subgroup.

摘要

脑小血管病(SVD)可导致局灶性腔隙性梗死和更弥漫性的缺血,即脑白质疏松症。内皮功能障碍被认为是该病的一种致病机制。同型半胱氨酸对内皮有毒性作用。我们确定了同型半胱氨酸水平升高和亚甲基四氢叶酸还原酶(MTHFR)C677T多态性是否是整个SVD以及两种不同SVD亚型(孤立性腔隙性梗死和缺血性脑白质疏松症)的危险因素。我们还确定了是否存在由循环内皮标志物评估的内皮功能障碍介导的任何关联。对172例患有SVD的白种人患者和172例年龄和性别相似的社区对照者进行了研究。进行了血清同型半胱氨酸测量和MTHFR基因分型。在一个亚组中测量了细胞间黏附分子1(ICAM1)和血栓调节蛋白的水平。SVD患者的平均同型半胱氨酸水平高于对照组[14.55微摩尔/升[95%置信区间(CI)13.78 - 15.35],而对照组为12.01微摩尔/升(95%CI 11.42 - 12.64),P < 0.0005]。在控制了传统危险因素和年龄后,与孤立性腔隙性梗死[4.22(95%CI 1.29 - 13.73),P = 0.02]相比,同型半胱氨酸是缺血性脑白质疏松症患者中更强的危险因素[每微摩尔对数同型半胱氨酸浓度增加时为12.92(95%CI 4.40 - 37.98),P < 0.0005](P < 0.0005)。MTHFR 677T等位基因仅是缺血性脑白质疏松症组中的危险因素[比值比(OR)2.02(95%CI 1.31 - 3.1),P = 0.001]。在逻辑回归模型中纳入内皮标志物ICAM1和血栓调节蛋白后,同型半胱氨酸与SVD之间的关联不再显著。总之,高同型半胱氨酸血症是SVD尤其是缺血性脑白质疏松症的独立危险因素,且这种作用可能通过内皮功能障碍介导。降低同型半胱氨酸的治疗在该亚组中可能特别有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验